Skip to content

ARCHITECT 1L82-37Recalls & reported problems

Abbott Ireland Diagnostics · ARCHITECT AUSAB Reagent · Class 2

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380740115371), received between Oct 3, 2018 and Aug 23, 2024 — classified as 2 malfunctions.

The most frequently reported specific device problem is “False Positive Result” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • False Positive Result2
  • High Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 23, 2024False Positive Result; High Test Results; False Positive Result; High Test Results

    THE CUSTOMER OBSERVED A FALSE REACTIVE ARCHITECT AUSAB FOR ONE PATIENT. THE FOLLOWING RESULTS WERE PROVIDED: (B)(6) 2024, SID (B)(6), INITIAL ANTI-HBS= REACTIVE; REPEATED IN DUPLICATE= REACTIVE. THE PATIENT SAMPLE WAS SENT OUT TO A REFERENCE LAB ON (B)(6) 2024, ANTI-HBS CAME BACK NON-REACTIVE. THERE WAS NO IMPACT TO PATIENT MANAGEMENT REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20048316 ↗
  • MalfunctionOct 3, 2018False Positive Result; False Positive Result

    THE CUSTOMER REPORTED ERRATIC AND FALSELY ELEVATED ARCHITECT AUSAB RESULTS. SAMPLE ID (B)(6) WHICH GENERATED MULTIPLE NEGATIVE RESULTS (6.97, 3.65, 3.55 AND 3.98 MIU/ML) AND ONE REACTIVE RESULT OF 69.19 MIU/ML). NO SPECIFIC PATIENT INFORMATION WAS PROVIDED. NO ADVERSE IMPACT TO PATIENT MANAGEMENT WAS REPORTED.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 7929600 ↗

Other Test, hepatitis b (b core, be antigen, be antibody, b core igm) devices

All Test, hepatitis b (b core, be antigen, be antibody, b core igm) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.